perfluorooctane sulfonic acid has been researched along with Adenomatous Polyposis Coli in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Innes, K; Kamarec, S; Montgomery, C; Thomas, L; Villers, M; Wimsatt, J; Yeung, LW | 1 |
1 other study(ies) available for perfluorooctane sulfonic acid and Adenomatous Polyposis Coli
Article | Year |
---|---|
Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APC
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Administration, Oral; Alkanesulfonic Acids; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluorocarbons; Male; Mice; Mice, Inbred C57BL | 2016 |